These data are in accordance with previous studies that have shown how in animal models of diabetes, induced by streptozotocin administration, there was a decrease in expression in the BBB of both GLUT1 and GLUT3 [60]. This evidence concerns the gene SLC2A1 and diabetes mellitus.